George Farmer
Stock Analyst at Scotiabank
(2.95)
# 1,394
Out of 5,090 analysts
70
Total ratings
44.74%
Success rate
1.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.22 | +719.67% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $69.56 | +91.20% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.91 | -68.59% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $22.98 | +104.53% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $20.32 | -16.34% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $5.58 | +115.05% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $3.12 | +188.46% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $16.51 | +148.33% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $35.26 | +47.48% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $53.40 | +49.81% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $181.30 | +23.55% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $38.55 | +164.59% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $11.95 | -16.32% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $901.17 | -20.66% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $6.43 | +257.70% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $1.20 | +1,566.67% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $28.13 | +170.17% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.58 | +263.13% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $27.70 | +293.50% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $102.52 | -15.14% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.67 | +1,135.96% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.66 | +5,918.66% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $44.36 | -39.13% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.22
Upside: +719.67%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $69.56
Upside: +91.20%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.91
Upside: -68.59%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $22.98
Upside: +104.53%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $20.32
Upside: -16.34%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $5.58
Upside: +115.05%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $3.12
Upside: +188.46%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $16.51
Upside: +148.33%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $35.26
Upside: +47.48%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $53.40
Upside: +49.81%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $181.30
Upside: +23.55%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $38.55
Upside: +164.59%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $11.95
Upside: -16.32%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $901.17
Upside: -20.66%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $6.43
Upside: +257.70%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $1.20
Upside: +1,566.67%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $28.13
Upside: +170.17%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.58
Upside: +263.13%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $27.70
Upside: +293.50%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $102.52
Upside: -15.14%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.67
Upside: +1,135.96%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.66
Upside: +5,918.66%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $44.36
Upside: -39.13%